David Artis, PhD, Weill Cornell Medicine, New York, USA
Bana Jabri, MD, PhD, University of Chicago, Department of Medicine, Chicago, USA
Yasmine Belkaid, PhD, NIH National Institute of Allergy and Infectious Diseases, Bethesda, USA
Speakers – Joint Plenary Sessions
Marco Colonna, MD, Professor, Pathology & Immunology, Washington University St. Louis, USA
Anna Molofsky, MD, PhD, Assistant Professor, Department of Psychiatry, UCSF Weill Institute for Neurosciences, San Francisco, USA
Ari Molofsky, MD, PhD, Associate Clinical Professor, Assistant Director of Clinical Labs Immunology Section, University of California, San Francisco, USA
Kazuyo Moro, DDS, PhD, Department of Microbiology and Immunology, Graduate school of Medicine, Osaka University; RIKEN Center for Integrative Medical Sciences (IMS); Immunology Frontier Research Center (IFReC), Osaka University, Japan
Henrique Veiga-Fernandes, PhD, Champalimaud Research Director and Senior Group Leader, Champalimaud Foundation, Lisbon, Portugal
Speakers ILC4 Sessions
Gabrielle Belz, PhD, The University Queensland Diamantina Institute and The Walter and Eliza Hall Institute of Medical Research
Andreas Diefenbach, PhD, Director, Institute of Microbiology, Infectious Diseases and Immunology, Charité – Universitätsmedizin Berlin, Germany
James Di Santo, MD, PhD, Innate Immunity Unit, Department of Immunology, Institut Pasteur, Paris, France
Gérard Eberl, PhD, Department of Immunology, Microenvironment & Immunity Unit, Institut Pasteur, Paris, France
Georg Gasteiger, MD, PhD, University of Würzburg, Germany
Shigeo Koyasu, D.Sc., Executive Director, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Lewis Lanier, PhD, Professor, Microbiology and Immunology Chair, Microbiology and Immunology, University of California, San Francisco, USA
Richard M. Locksley, MD, Sandler Distinguished Professor of Medicine and director of the Sandler Asthma Basic Research Center at University of California, San Francisco, USA
Andrew McKenzie, PhD, University of Cambridge, Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, UK
Jenny Mjösberg, PhD, Center for Infectious Medicine, ANA Futura Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Fiona Powrie, FRS, Professor of Musculoskeletal Sciences and Director of the Kennedy Institute of Rheumatology, University of Oxford, UK
Chiara Romagnani, MD PhD, Innate Immunity, German Rheumatism Center (DRFZ) and Charitè Medical University Berlin, Germany
Gregory Sonnenberg, PhD, Associate Professor of Microbiology and Immunology in Medicine, Weill Cornell Medicine, USA
